| Author |
Message |
havana8
Moderator
 
Joined: 09 Sep 2005
Posts: 3451
|
|
 |
Tue Jul 22, 2008 6:46 pm  |
IS Clinical has launched a new line ADVANCE+ that combines (time-released) L-Ascorbic Acid with Copper Tripeptide Growth Factor! 
IS Clinical Launches New ADVANCE+ Skincare Line
NEW YORK, June 19, 2008 /PRNewswire via COMTEX/ -- IS Clinical, an exclusive skincare brand by INNOVATIVE SKINCARE, has raised the bar once again in formulation and ingredient technology with the highly-effective, clinically-validated skincare line: ADVANCE+.
The Innovative Skincare R&D team sourced a new version of L-Ascorbic Acid (Vitamin C) technology to employ in the ADVANCE+ formulas. This version of L-Ascorbic Acid offers time-released, continuous and steady delivery to cells, providing a more efficient and effective form of the powerhouse ingredient. Additionally, its uniquely stabilized molecular structure allows it to be formulated with other potent ingredients, previously thought impossible, to enable enhanced collagen production and additional anti-aging benefits.
Innovative Skincare's expert team of PhDs, under the direction of Medical Director Charlene DeHaven, MD, FACEP, directed the development of the line from concept to market, including: sourcing the ingredients worldwide and coordinated independent clinical testing on all formulations for safety and efficacy. In an effort to uphold supreme ethical standards and adhere to strict medical guidelines, Innovative Skincare is moving forward without the involvement of former R&D team member Dr. Mostafa Omar, and by extension Phytoceuticals, Inc.
http://www.marketwatch.com/news/story/clinical-launches-new-advance-skincare/story.aspx?guid=%7B3AEECD06-15CD-4A01-8C9F-D0CCFB3C628D%7D
The ADVANCE+ line features a new cutting-edge vitamin C (L ascorbic acid) technology along with Copper Tripeptide Growth Factor (in select products) to produce more rapid, pronounced improvements in the skin that ever before.
http://www.isclinical.com/
Super Serum ADVANCE+
3.5 pH +/- .25
Ingredients: water, 15% L-ascorbic acid, hyaluronic acid, pentylene glycol, urea, glucose, guanidine, tripeptide-1, 0.5% arbutin, 0.5% kojic acid (mushroom extract), calcium pentothenate, asiaticoside, asiatic acid, madecassis acid, zinc sulfate, glycerin, phenoxyethanol
Pro-Heal Serum ADVANCE+
3.1 pH +/- .25
Ingredients: water, 15% L-ascorbic acid (Vitamin C), laureth-4, alcohol denat, pentylene glycol, propylene glycol, 0.5% olive leaf extract, zinc sulfate, 1% tocopherol (Vitamin E), 0.5% kojic acid (mushroom extract), arbutin, glycerin, bioflavinoids, 1% retinol (Vitamin A), polysorbate 20, phenoxyethanol
C Eye ADVANCE+
3.0 pH +/- .25
Ingredients: water, sodium hyaluronate, L-Ascorbic acid, propylene glycol, zinc sulfate, dextrin, tripeptide-1, bioflavonoids, mushroom extract, phenoxyethanol |
|
|
havana8
Moderator
Joined: 09 Sep 2005
Posts: 3451
|
|
|
Tue Jul 22, 2008 6:54 pm |
And then I ran across this....
Termination of IS Clinical From Distributing PhytoCeuticals Formulas
ELMWOOD PARK, N.J., July 2 /PRNewswire/ -- PhytoCeuticals, Inc., the highly respected developer and manufacturer of proprietary skin care formulations, who is the first to invent Stable Liquid L-Ascorbic Acid (Vitamin C), has terminated the agreement granting IS Clinical from Innovative Skin Care the right to exclusively market the proprietary product formulas of PhytoCeuticals, Inc. effective July 1, 2008.
The IS Clinical termination was triggered by that company's introduction of controversial new products, not created by PhytoCeuticals, Inc. that violated Dr. Mostafa M. Omar, presidents of PhytoCeuticals, Inc. medical guidelines. Dr. Omar is also the Professor of Pharmacognosy at the University of Rhode Island, School of Pharmacy commented, "It is my ethical duty as a prominent medical researcher to warn clinicians and patients that, as IS clinical no longer has access to PhytoCeuticals, Inc. formulas and products, I cannot warrant the safety of any products sold by IS Clinical."
IS Clinical has received legal notice to remove all references to Dr. Omar and/or PhytoCeuticals, Inc., including all research citations, product claims and other related materials from all websites, advertising materials, media releases, packaging and product literature. Also IS Clinical is required to issue a clarifying press release informing clinicians and consumers, which products sold by the company prior to July 1, 2008, were actually owned and developed by PhytoCeuticals, Inc. -- a business relationship that no longer exists.
"We will take all action necessary to prohibit IS clinical from illegal usage of our formulas and research,' added Dr. Omar. "We will protect our scientific integrity and the reputation of our unique, clinically-proven products by any and all legal means."
PhytoCeuticals, Inc. is highly respected developer and manufacturing of proprietary skin care formulations, who is the First to invent Stable Liquid L-Ascorbic Acid (Vitamin C) in the market place in early 1990. The company had awarded many grants from National Cancer Institute (NCI) and National Institute of Health (NIH) to test all its formulations clinically over 18 years. The products are no longer available from IS Clinical but directly from PhytoCeuticals, Inc.
1. Active serum
2. Hydra cool gel
3. Polyvitamin gel
4. Skin Firming Cream
5. Eye Contour Cream
6. Body Lotion
7. Topical Vitamin C Eye Gel
8. Topical Vitamin C 15% serum
9. Topical Vitamin C&E serum
10. Proheal Serum (Topical Vitamin C,E,A, Olive Leaves Extract)
11. Super Serum
12. Moisturizing Cream
For further information, please contact Dr. Mostafa M. Omar, the President of PhytoCeuticals, Inc. directly at 201-791-2255 or phytoceuticals@msn.com.
http://www.bio-medicine.org/medicine-news-1/Termination-of-IS-Clinical-From-Distributing-PhytoCeuticals-Formulas-23140-1/ |
|
|
havana8
Moderator
Joined: 09 Sep 2005
Posts: 3451
|
|
|
Wed Jul 23, 2008 5:49 pm |
Bushy, as I understand it, tripeptide-1 is the INCI name for the GHK peptide. What's confusing to me is that I would have expected "copper" before "tripeptide-1" as described on the ISC website but then again, I am no chemist.  Hopefully someone who better understands it all will be able to enlighten.
http://www.cs-peptide.com/prod_detail.php?pid=31
Since the release states that the original formulations and products are owned by PhytoCeuticals, it sounds as if ISC will need to reformulate some of their core products or develop completely new ones. I wonder who will keep the product names and I wonder how much cross-over there will be between the two in terms of product line-ups and marketing, etc.? Sounds messy.
It will definitely be interesting to see how it all unfolds with so many products affected by the split. |
|
|
|
|
| Sun Dec 29, 2024 1:18 am |
If this is your first visit to the EDS Forums please take the time to register. Registration is required for you to post on the forums. Registration will also give you the ability to track messages of interest, send private messages to other users, participate in Gift Certificates draws and enjoy automatic discounts for shopping at our online store. Registration is free and takes just a few seconds to complete.
Click Here to join our community.
If you are already a registered member on the forums, please login to gain full access to the site. |
|
 |
|
|
